<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-91e9c5c4=""><div class="content_outer_container" data-v-91e9c5c4=""><div class="share_preview_container" data-v-91e9c5c4=""><div class="dialog_list" data-v-91e9c5c4=""><div class="dialog_item" data-v-91e9c5c4=""><div class="dialog_question fir_dialog_question" data-v-91e9c5c4=""><div class="dialog_content" data-v-91e9c5c4=""><h1 class="fir_question_content" data-v-91e9c5c4="">
                                    How did VERV's Q4 2024 earnings surprise investors?
                                </h1> <div class="user_slot" data-v-91e9c5c4=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-91e9c5c4=""> <span class="user_desction" data-v-91e9c5c4="">
                                        
                                        4/3/2025 02:18pm
                                    </span></div></div></div> <div class="seo-text-answer" data-v-91e9c5c4="">Verve Therapeutics (VERV) reported an earnings per share (EPS) surprise of $0.09 for Q4 2024, compared to the analyst consensus. This positive surprise indicates that the company's actual performance exceeded market expectations, likely due to factors such as effective cost management, higher revenue, or a combination of both. Investors may react positively to this news, as it suggests that the company is managing its finances better than anticipated.

</div> <div class="dialog_answer" data-v-91e9c5c4=""><div class="dialog_content" data-v-91e9c5c4=""> <div class="answer_robot" data-v-91e9c5c4=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/AIme.ae832fb.png" alt="robot" class="avatar" data-v-91e9c5c4=""> <div class="user_name" data-v-91e9c5c4=""></div></div> <div class="question_content" data-v-91e9c5c4=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-4e97ba8a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-4e97ba8a=""> <div class="recommend-part" data-v-7790c618="" data-v-4e97ba8a=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an,ao,ap,aq,ar,as,at,au,av,aw,ax,ay,az,aA,aB,aC,aD,aE,aF,aG,aH){return {layout:"default",data:[{noData:c,currentQuestion:l,textDescription:N,comeFrom:"AInvestShareLink",events:[],answerSource:w}],fetch:{},error:p,state:{sharePreviewModule:{loadJgySuccess:f,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:q,agent_id:a,output_media_info:[],task_id:a,language:a,source:w,cache_builder:a,reply_action:"Answer",execute_mode:A,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How did VERV's Q4 2024 earnings surprise investors?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How did VERV's Q4 2024 earnings surprise investors?\",\"user_id\":\"dp69565997\",\"user_name\":\"\",\"trace_id\":\"8c3c54b9-cadb-47ce-8c40-04bcfbdf0764\",\"session_id\":\"8c3c54b9-cadb-47ce-8c40-04bcfbdf0764\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:"query_data",query_type:B,text:"1 results found:\n|stock code|stock name|Last Price|Last Change|EPS Surprise[20241231]|\n|---|---|---|---|---|\n|VERV|Verve Therapeutics|$3.91|-5.44%|0.09|\n",query_data:{number:O,title:C,query_type:B,condition:a,model_sql:P,data_ext_params:{merge_repeat:c,expand_index:b,data_add:q,add_index:f}}}],answer_chain_name:Q,agent_mode:R,native_answer:a,come_from:a,text_answer:N,trace_id:r,cost:18113,event_names:a,question:l,fallback_type:S,input_type:"typewrite",fall_back_reason:{fall_back_type:S,risk_detail:{matched_words:[]}},session_id:r,first_return_cost:3252,cache_type:a,question_id:r,transfer_question:l,signal_type:"ON_COMPLETE",start_time:T,remote_svc:w,slots:[],answer_type:A,user_id:D,skill_name:E},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:r,session_id:r,user_id:D,question:l,source:w,raw_question:l,version:"3.4.1",action_name:E,nlu:{entity:[{type:U,value:V,market:F}]},deep_research:c,deep_thinking:c,agent_mode:R},extra:{}},{answer_path:h,section:{id:i,info_texts:["Thinking"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:h,section:{id:i,info_texts:["Querying Stock: VERV Latest Report Period"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:x},logs:[],extra:{action:G,action_input:"VERV Latest Report Period",thought:"The user wants to evaluate how VERV's Q4 2024 earnings report exceeded market expectations. I should focus on the earnings report, earnings surprise, analyst opinions, and market analysis. I will use FinQuery for the latest report period to obtain the latest report period. Then, use FinQuery for earnings data, analyst opinions, and search for market analysis in the latest report period."}},{answer_path:d,section:{id:m,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:h,section:{id:i,info_texts:["Querying Stock: VERV Earnings Surprise in Fiscal 2024Q4"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:x},logs:[],extra:{action:G,action_input:C,thought:H}},{answer_path:h,section:{id:i,info_texts:["Querying Stock: VERV Analyst Consensus Rating, Analyst Average Price Target in Fiscal 2024Q4"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:x},logs:[],extra:{action:G,action_input:"VERV Analyst Consensus Rating, Analyst Average Price Target in Fiscal 2024Q4",thought:H}},{answer_path:h,section:{id:i,info_texts:["Searching Web: Verve Therapeutics market analysis in Fiscal 2024Q4"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:x},logs:[],extra:{action:"Searching Web",action_input:"Verve Therapeutics market analysis in Fiscal 2024Q4",thought:H}},{answer_path:d,section:{id:m,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:h,section:{id:i,info_texts:["Generating Answer"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:d,section:{id:n,info_texts:[],show_type:s,voice_txt:"V",text_answer:W,rich_text:W,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:2000,info_texts:[],show_type:s,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:C,query_type:B,trace_data:a,index:O,model_sql:P,data_ext_params:{merge_repeat:c,expand_index:b,data_add:q,add_index:f},jump_type:"data_query"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:n,info_texts:[],show_type:s,voice_txt:". This",text_answer:X,rich_text:X,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:Y,market_id:F,name:Z,domain:U},pos:f,section_id:n,txt:Z,jump_type:"pos_fenshi"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:n,info_texts:[],show_type:s,voice_txt:"\n",text_answer:_,rich_text:_,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:n,info_texts:[],show_type:$,choice:[],result_page:{components:[{category:aa,puuid:ab,request_config:[{related_name:ac,source_type:I}],show_type:ad,tag:"Analyst Estimate Earnings",uuid:ae,title_config:{config:{display:c,display2:c,txt_style:f,type:af,url:a},data:{h1:a,h2:a},show_type:ag}}],global:{interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:ah,label:y,type:ai,leaf:c,animate:[],version:aj,script:[],props:{test:a},path:ak,style:{"background-color":a,"box-shadow":al,color:a,width:g,"min-height":am,position:z,height:g},isMaterial:c,id:y,needTheme:c,hasEditor:c,packed:c,events:[],child:[{stack:c,visible:b,childLimit:f,label:"财报",type:an,leaf:b,version:"0.0.1",animate:[],url:J,componentUuid:ae,script:[{name:"earnings",id:65539,content:"return {\r\n  mounted () {\r\n    window.__oversea_ainvest__ = {\r\n      ENV: \"production\"\r\n    }\r\n  }\r\n}"}],props:{title:"Earnings"},path:J,meta:{js_url:J},style:{"background-color":a,padding:"0",color:a,display:ao,width:g,position:z,height:g},isMaterial:b,_id:ap,id:an,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]},lowcode_type:aq,urp_static_data:[{name:ac,value:{columns:[{index_name:ar,key:ar,type:e},{index_name:as,key:as,type:e}],dataSize:q,datas:[{code:Y,market_code:F}]}},{name:"advance_custom_visual",value:{columns:[{index_name:at,key:at,type:e},{index_name:au,key:au,type:e},{index_name:av,key:av,type:e}],dataSize:q,datas:[{stock_code:V,start_date:"2024-01-01",end_date:"2024-12-31"}]}}]},page:{layout:{layout_data:"[{\"uuid\":\"gyyEarnings\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:K,uuid:ab,voice_txt:a}},tag_info_list:[],is_last:c,uuid:"4a665cea-52c9-4dda-9815-5bb4c96bf510"},logs:[],extra:{}},{answer_path:d,section:{id:n,info_texts:[],show_type:s,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:h,section:{id:i,info_texts:["Completed"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:$,choice:[{display_text:t,query_text:t,trace_info:{item_id:"73967d1eff14fbfe25691d872f6e5a5c",item_type:o,item_name:t,rec_info:aw}},{display_text:u,query_text:u,trace_info:{item_id:"33df77f50c540a47277f28d93fbf4f9f",item_type:o,item_name:u,rec_info:ax}},{display_text:v,query_text:v,trace_info:{item_id:"6ce9cc2f912276e5715c8937f76e25a3",item_type:o,item_name:v,rec_info:ay}}],result_page:{components:[{show_type:ad,title_config:{show_type:ag,data:{h1:a,h2:a},config:{display:c,txt_style:f,type:af,display2:c,url:a}},request_config:[{source_type:I,related_name:az}],puuid:L,tag:a,category:aa,uuid:aA}],global:{urp_static_data:[{name:az,value:{status_code:f,columns:[{type:e,index_name:aB,key:aB},{type:e,index_name:aC,key:aC},{type:e,index_name:aD,key:aD},{type:e,index_name:aE,key:aE},{type:e,index_name:aF,key:aF}],datas:[{send_text:t,item_type:o,rec_info:aw,display_text:t,rec_reason:a},{send_text:u,item_type:o,rec_info:ax,display_text:u,rec_reason:a},{send_text:v,item_type:o,rec_info:ay,display_text:v,rec_reason:a}],dataSize:I,status_msg:a}}],lowcode_type:aq,interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:ah,label:y,type:ai,leaf:c,animate:[],version:aj,script:[],props:[],path:ak,isTransparent:b,style:{"background-color":a,"box-shadow":al,color:a,width:g,"min-height":am,position:z,height:g},isMaterial:c,id:y,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:f,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:M,componentUuid:aA,script:[{name:aG,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:M,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:M},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:ao,width:g,position:z,height:g},isMaterial:b,_id:ap,id:aG,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:K,voice_txt:a,tracking_info:{},uuid:L},order:{is_auto:c,render_for:K,chart_type:"command",puuid:L}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1005,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:E,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:A,answer_chain_name:Q},is_deep_research:c,deep_thinking:c,create_time:1743661152272},is_last:b}],questionItem:{data:{qStr:l,encodeFlag:c,imageData:p,docsData:[],quoteData:p},tplType:"question"},events:[],agentId:a}],userId:D,userName:a,startTime:T,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:p,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],traceTableData:p,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Fvervs-q4-2024-earnings-surprise-investors-35eb42\u002F",config:{_app:{basePath:aH,assetsPath:aH,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,"other\u002FopenAnswer","STR",0,"auto","progress\u002Fsearching_for",1000,"searching_for","signal","How did VERV's Q4 2024 earnings surprise investors?",999,2001,"llm_generated",null,1,"8c3c54b9-cadb-47ce-8c40-04bcfbdf0764","rich_text","📊 How did VERV's Q4 2024 earnings compare to analyst expectations?","❓ How did VERV's management explain the earnings surprise during the earnings call?","🛡️ What factors contributed to VERV's earnings surprise in Q4 2024?","ths_ainvest_lite_web","thinking","root","relative","agent","intusstock","VERV Earnings Surprise in Fiscal 2024Q4","dp69565997","explain news events","185","Querying Stock","I have obtained the latest report period of VERV is 2024Q4. Now I will use FinQuery to obtain the earnings data, analyst opinions, and use Search to find market analysis in the latest report period.",3,"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002Fearnings\u002F0.0.1\u002Fearnings@0.0.1index.js","aigc","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Verve Therapeutics (VERV) reported an earnings per share (EPS) surprise of $0.09 for Q4 2024, compared to the analyst consensus. This positive surprise indicates that the company's actual performance exceeded market expectations, likely due to factors such as effective cost management, higher revenue, or a combination of both. Investors may react positively to this news, as it suggests that the company is managing its finances better than anticipated.\n\n",2,"select   stock_code,   eps_surprise from   ustock_fin_forecast where   fiscal_date = date('2024y4q')   and stock_code = 'VERV.O'","agent_common_v2\nagent-summary","normal_agent","NONE",1743661134160,"stock","VERV.O","Verve Therapeutics (VERV) reported an earnings per share (EPS) surprise of $0.09 for Q4 2024, compared to the analyst consensus[^2]",". This positive surprise indicates that the company's actual performance exceeded market expectations, likely due to factors such as effective cost management, higher revenue, or a combination of both. Investors may react positively to this news, as it suggests that the company is managing its finances better than anticipated.\n\n","VERV","Verve Therapeutics","\n``` visual\n{\"uuid\":\"4a665cea-52c9-4dda-9815-5bb4c96bf510\"}\n```","result_page","custom","39192","code_entity","lowcode","gyyEarnings","1","title1",9999,"thslc\u002Fthslc-common-container","1.0.1","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js","0px 0px 0px","100%","iwencai\u002Fearnings","block",19,"shunda","market_code","code","stock_code","end_date","start_date","2+706_496_21_554+0+0+8c3c54b9-cadb-47ce-8c40-04bcfbdf0764+73967d1eff14fbfe25691d872f6e5a5c+llm_generated+aimeTagAnalysis+0+0.061743687838315964+1","2+706_496_21_554+0+0+8c3c54b9-cadb-47ce-8c40-04bcfbdf0764+33df77f50c540a47277f28d93fbf4f9f+llm_generated+aimeTagAnalysis+0+0.04101565107703209+2","2+706_496_21_554+0+0+8c3c54b9-cadb-47ce-8c40-04bcfbdf0764+6ce9cc2f912276e5715c8937f76e25a3+llm_generated+aimeTagAnalysis+0+0.03733762353658676+3","recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","iwencai\u002FrecommendList0326","\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/195837b.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/e402278.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7c15041.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/69a864a.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/9579193.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/6726d3c.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/c69ce63.js" defer=""></script>